HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oriss, T. B. Articles by Wright, T. M. Search for Related Content PubMed PubMed Citation Articles by Oriss, T. B. Articles by Wright, T. M.

Distinct Autoreactive T Cell Responses to Native and Fragmented DNA Topoisomerase I: Influence of APC Type and IL-2¹

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, University of Pittsburgh Arthritis Institute, Pittsburgh, PA 15261

Systemic sclerosis (SSc) is an autoimmune connective tissue disease of unknown etiology in which T cell responses to various autoantigens, including DNA topoisomerase I (Topo I), have been implicated. We investigated whether dendritic cells, generally considered to be the most potent APCs for the initiation of immune responses, would present either of two forms of Topo I to T cells more efficiently than PBMC APCs. Using cells from healthy controls and SSc patients, several important observations were made. First, neither APC type was able to initiate T cell proliferative responses to full-length native Topo I unless exogenous IL-2 was added. This is in contrast to vigorous T cell proliferation in response to Topo I polypeptide fragments presented by either APC type. Second, T cell responses to the full-length form of Topo I presented by dendritic cells were considerably lower than responses to Ag presented by PBMC APCs. Finally, no secondary T cell responses were observed unless the same Ag/APC combination as that used in the primary stimulation was maintained. These data indicate that different peptides are generated based upon the form of the Topo I and the APC that processes it. Taken together, these results suggest that a very specific combination of antigenic form and APC may be involved in breaking tolerance to Topo I in the early stages of development of SSc.

This article has been cited by other articles:

				S Veeraraghavan, E A Renzoni, H Jeal, M Jones, J Hammer, A U Wells, C M Black, K I Welsh, and R M du Bois Mapping of the immunodominant T cell epitopes of the protein topoisomerase I Ann Rheum Dis, August 1, 2004; 63(8): 982 - 987. [Abstract] [Full Text] [PDF]

				R. L. Ferris and W. M. Koch Connective Tissue Disease Coincident With Nasopharyngeal Carcinoma: Two Sporadic Cases in a Western Population Arch Otolaryngol Head Neck Surg, January 1, 2003; 129(1): 101 - 105. [Abstract] [Full Text] [PDF]

				D. P. Ascherman, T. B. Oriss, C. V. Oddis, and T. M. Wright Critical Requirement for Professional APCs in Eliciting T Cell Responses to Novel Fragments of Histidyl-tRNA Synthetase (Jo-1) in Jo-1 Antibody-Positive Polymyositis J. Immunol., December 15, 2002; 169(12): 7127 - 7134. [Abstract] [Full Text] [PDF]